PMC:7095437 / 573-953 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"17","span":{"begin":212,"end":247},"obj":"Disease"},{"id":"21","span":{"begin":314,"end":338},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"MESH:D008171"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ere assigned to the early-stage group (onset of symptoms within 4 days) or progressive-stage group (onset of symptoms within 4–7 days) for analysis. CT characteristics and the distribution, size, and CT score of pulmonary parenchymal abnormalities were assessed.\n\nResults\nIn our study, the major characteristic of coronavirus disease 2019 was ground-glass opacity (61.3%), followe"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T4","span":{"begin":314,"end":338},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ere assigned to the early-stage group (onset of symptoms within 4 days) or progressive-stage group (onset of symptoms within 4–7 days) for analysis. CT characteristics and the distribution, size, and CT score of pulmonary parenchymal abnormalities were assessed.\n\nResults\nIn our study, the major characteristic of coronavirus disease 2019 was ground-glass opacity (61.3%), followe"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":32,"end":37},"obj":"Chemical"},{"id":"T3","span":{"begin":93,"end":98},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"ere assigned to the early-stage group (onset of symptoms within 4 days) or progressive-stage group (onset of symptoms within 4–7 days) for analysis. CT characteristics and the distribution, size, and CT score of pulmonary parenchymal abnormalities were assessed.\n\nResults\nIn our study, the major characteristic of coronavirus disease 2019 was ground-glass opacity (61.3%), followe"}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":149,"end":262},"obj":"Sentence"},{"id":"T9","span":{"begin":264,"end":271},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ere assigned to the early-stage group (onset of symptoms within 4 days) or progressive-stage group (onset of symptoms within 4–7 days) for analysis. CT characteristics and the distribution, size, and CT score of pulmonary parenchymal abnormalities were assessed.\n\nResults\nIn our study, the major characteristic of coronavirus disease 2019 was ground-glass opacity (61.3%), followe"}